Thus, there is a vicious cycle among oxidative stress, inflammation and mitochondrial dysfunction, and breaking this cycle may be a therapeutic target for the treatment of age-related insulin resistance and T2DM, focusing on SIRT1, SIRT2, SIRT3, and SIRT6 (Figure 1). Here, SIRT2 is linked to type 2 diabetes mellitus.